About 4 results found for searched term "Dapagliflozin" (0.119 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1937 | Dapagliflozin | SGLT |
| BMS-512148 | ||
| Dapagliflozin (BMS-512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2). | ||
| M5551 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) | SGLT |
| BMS-512148 (2S)-1,2-propanediol, hydrate | ||
| Dapagliflozin ((2S)-1,2-propanediol, hydrate) is the S-enantiomer of Dapagliflozin 1,2-propanediol, hydrate. | ||
| M22213 | Dapagliflozin impurity | SGLT |
| Dapagliflozin impurity is the enantiomeric form of Dapagliflozin, a sodium-glucose transporter 2 inhibitor. | ||
| M55678 | Dapagliflozin-3-O-β-D-glucuronide | Metabolite/Endogenous Metabolite |
| BMS-801576 | ||
| Dapagliflozin-3-O-β-D-glucuronide (BMS-801576) is the metabolite of Dapagliflozin, and is formed in the liver and kidney by uridine diphosphate glucuronosyltransferase-1A9 (UGT1A9). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
